Certara, Inc.(CERT)Earnings, Financials & Key Ratios

CERT•NASDAQ

$6.26

$1.03B mkt cap·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryLife Sciences and Precision Medicine Software

AboutCertara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.Show more

Revenue$419M+8.7%
EBITDA$78M+17.0%
Net Income-$2M+86.8%
EPS (Diluted)-0.01+86.7%
Gross Margin61.53%+2.8%
EBITDA Margin18.52%+7.6%
Operating Margin5.02%+1216.5%
Net Margin-0.38%+87.8%
ROE-0.15%+86.9%
ROIC1.52%+1448.5%
Debt/Equity0.01-96.4%

Technical→

CERT Key Insights

Certara, Inc. (CERT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓FCF machine: 22.6% free cash flow margin
✓Strong 5Y sales CAGR of 11.5%
✓Trading at only 0.9x book value

✗Weaknesses

✗Weak momentum: RS Rating 12 (bottom 12%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CERT Price & Volume

Certara, Inc. (CERT) stock price & volume — 10-year historical chart

Loading chart...

CERT Growth Metrics

Certara, Inc. (CERT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years11.45%

3 Years7.66%

TTM8.75%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM86.76%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM86.7%

Return on Capital

10 Years0.14%

5 Years0.37%

3 Years-0.48%

Last Year1.48%

CERT Recent Earnings

Certara, Inc. (CERT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 4/12 qtrs (33%)●Beat Revenue 7/12 qtrs (58%)

Q1 2026Latest

Feb 26, 2026

EPS

$0.09

Est $0.11

-18.2%

Revenue

$104M

Est $103M

+0.5%

Q4 2025

Nov 6, 2025

EPS

$0.14

Est $0.11

+27.3%

Revenue

$105M

Est $103M

+1.3%

Q3 2025

Aug 6, 2025

EPS

$0.07

Est $0.10

-30.0%

Revenue

$105M

Est $104M

+0.5%

Q2 2025

May 5, 2025

EPS

$0.14

Est $0.13

+7.7%

Revenue

$106M

Est $104M

+1.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 26, 2026	$0.09vs $0.11-18.2%	$104Mvs $103M+0.5%
Q4 2025	Nov 6, 2025	$0.14vs $0.11+27.3%	$105Mvs $103M+1.3%
Q3 2025	Aug 6, 2025	$0.07vs $0.10-30.0%	$105Mvs $104M+0.5%
Q2 2025	May 5, 2025	$0.14vs $0.13+7.7%	$106Mvs $104M+1.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
MEDPMedpace Holdings, Inc.Direct Competitor	12.19B	426.79	27.93	19.97%	17.19%	120.89%	0.55
IQVIQVIA Holdings Inc.Direct Competitor	29.95B	176.47	22.51	5.87%	8.33%	22.11%	2.44
CRLCharles River Laboratories International, Inc.Direct Competitor	8.97B	181.73	-62.45	-0.85%	-3.59%	-4.34%	0.95
VEEVVeeva Systems Inc.Direct Competitor	27.2B	167.29	30.75	16.34%	28.44%	13.41%	0.01
SLPSimulations Plus, Inc.Product Competitor	319.93M	15.88	-4.93	13.09%	-81.66%	-50.54%	0.00
SDGRSchrödinger, Inc.Product Competitor	969.87M	12.98	-9.21	23.29%	-40.6%	-30.85%	0.30
RXRXRecursion Pharmaceuticals, Inc.Product Competitor	1.53B	3.43	-2.38	26.92%	-8.44%	-54.32%	0.07
EXLSExlService Holdings, Inc.Product Competitor	4.84B	30.97	20.11	13.56%	11.66%	27.16%	0.44

Compare CERT vs Peers

Certara, Inc. (CERT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MEDP

Most directly comparable listed peer for CERT.

Scale Benchmark

vs LLY

Larger-name benchmark to compare CERT against a more recognizable public peer.

Peer Set

Compare Top 5

vs MEDP, IQV, CRL, VEEV

CERT Income Statement

Certara, Inc. (CERT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	163.72M	208.51M	243.53M	286.1M	335.64M	354.34M	385.15M	418.84M
Revenue Growth %	-	27.36%	16.79%	17.48%	17.32%	5.57%	8.7%	8.75%
Cost of Goods Sold	71.04M	79.77M	100.77M	111.62M	132.58M	141.02M	154.52M	161.13M
COGS % of Revenue	43.39%	38.26%	41.38%	39.01%	39.5%	39.8%	40.12%	38.47%
Gross Profit	92.68M▲ 0%	128.74M▲ 38.9%	142.76M▲ 10.9%	174.49M▲ 22.2%	203.07M▲ 16.4%	213.31M▲ 5.0%	230.63M▲ 8.1%	257.71M▲ 11.7%
Gross Margin %	56.61%	61.74%	58.62%	60.99%	60.5%	60.2%	59.88%	61.53%
Gross Profit Growth %	-	38.92%	10.89%	22.22%	16.38%	5.05%	8.12%	11.74%
Operating Expenses	97.33M	109.13M	167.19M	160.91M	170.55M	254.09M	232.36M	180.14M
OpEx % of Revenue	59.45%	52.34%	68.65%	56.24%	50.81%	71.71%	60.33%	43.01%
Selling, General & Admin	52.81M	58.66M	107.68M	99.68M	99.18M	127.41M	120.97M	139.1M
SG&A % of Revenue	32.26%	28.13%	44.22%	34.84%	29.55%	35.96%	31.41%	33.21%
Research & Development	10.48M	11.63M	19.64M	20.38M	28.2M	34.17M	37.1M	41.04M
R&D % of Revenue	6.4%	5.58%	8.07%	7.12%	8.4%	9.64%	9.63%	9.8%
Other Operating Expenses	-107K	38.84M	39.86M	40.85M	43.16M	92.51M	74.29M	0
Operating Income	-4.65M▲ 0%	19.61M▲ 521.6%	-24.42M▼ 224.5%	13.58M▲ 155.6%	32.52M▲ 139.5%	-40.77M▼ 225.4%	-1.73M▲ 95.8%	21.02M▲ 1314.1%
Operating Margin %	-2.84%	9.41%	-10.03%	4.75%	9.69%	-11.51%	-0.45%	5.02%
Operating Income Growth %	-	521.6%	-224.51%	155.61%	139.49%	-225.38%	95.75%	1314.1%
EBITDA	32.36M	61.17M	18.33M	58.69M	84.99M	15.3M	66.3M	77.57M
EBITDA Margin %	19.77%	29.34%	7.53%	20.51%	25.32%	4.32%	17.21%	18.52%
EBITDA Growth %	-	89.04%	-70.03%	220.15%	44.8%	-82%	333.43%	17%
D&A (Non-Cash Add-back)	37.01M	41.56M	42.75M	45.12M	52.47M	56.07M	68.03M	56.56M
EBIT	-4.76M	18.85M	-24.89M	13.46M	36.53M	-32.23M	4.34M	0
Net Interest Income	-27.8M	-28M	-25.3M	-16.84M	-17.77M	-22.92M	-21.52M	0
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	27.8M	28M	25.3M	16.84M	17.77M	22.92M	21.52M	-19.74M
Other Income/Expense	-27.91M	-28.76M	-25.76M	-16.95M	-13.77M	-14.37M	-15.45M	-13.4M
Pretax Income	-32.56M▲ 0%	-9.15M▲ 71.9%	-50.18M▼ 448.4%	-3.38M▲ 93.3%	18.75M▲ 655.7%	-55.14M▼ 394.0%	-17.18M▲ 68.8%	7.62M▲ 144.3%
Pretax Margin %	-19.89%	-4.39%	-20.61%	-1.18%	5.59%	-15.56%	-4.46%	1.82%
Income Tax	697K	-225K	-784K	9.89M	4.02M	214K	-5.13M	9.21M
Effective Tax Rate %	-2.14%	2.46%	1.56%	-293.07%	21.46%	-0.39%	29.87%	120.94%
Net Income	-33.26M▲ 0%	-8.93M▲ 73.2%	-49.4M▼ 453.4%	-13.27M▲ 73.1%	14.73M▲ 211.0%	-55.36M▼ 475.8%	-12.05M▲ 78.2%	-1.59M▲ 86.8%
Net Margin %	-20.31%	-4.28%	-20.28%	-4.64%	4.39%	-15.62%	-3.13%	-0.38%
Net Income Growth %	-	73.16%	-453.41%	73.14%	211.04%	-475.79%	78.23%	86.76%
Net Income (Continuing)	-33.26M	-8.93M	-49.4M	-13.27M	14.73M	-55.36M	-12.05M	-1.59M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.25▲ 0%	-0.06▲ 77.3%	-0.32▼ 464.4%	-0.09▲ 72.3%	0.09▲ 204.4%	-0.35▼ 478.8%	-0.08▲ 78.5%	-0.01▲ 86.7%
EPS Growth %	-	77.32%	-464.37%	72.34%	204.41%	-478.79%	78.54%	86.68%
EPS (Basic)	-0.25	-0.06	-0.32	-0.09	0.09	-0.35	-0.08	-0.01
Diluted Shares Outstanding	132.41M	157.34M	152.98M	149.84M	159.35M	158.94M	160.39M	160.39M
Basic Shares Outstanding	132.41M	157.34M	152.98M	149.84M	156.88M	158.94M	160.39M	160.39M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

CERT Balance Sheet

Certara, Inc. (CERT) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	68.93M	87.52M	346.58M	274.73M	342.25M	340.2M	310.85M	315.12M
Cash & Short-Term Investments	11.68M	29.26M	271.38M	185.8M	236.59M	234.95M	179.18M	189.39M
Cash Only	11.68M	29.26M	271.38M	185.8M	236.59M	234.95M	179.18M	189.39M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	49.88M	52.36M	64.8M	78.31M	88.81M	93.26M	119.08M	103.53M
Days Sales Outstanding	111.21	91.65	97.12	99.9	96.57	96.06	112.85	90.22
Inventory	5.53M	0	0	0	0	0	0	0
Days Inventory Outstanding	28.43	-	-	-	-	-	-	-
Other Current Assets	3.32M	2.14M	3.03M	1.65M	8.47M	5.63M	4.27M	22.2M
Total Non-Current Assets	982.56M	949.55M	922.82M	1.24B	1.23B	1.22B	1.26B	1.24B
Property, Plant & Equipment	5.4M	4.62M	3.87M	15.57M	16.83M	12.27M	16.01M	13.79M
Fixed Asset Turnover	30.31x	45.10x	62.90x	18.38x	19.95x	28.87x	24.06x	30.37x
Goodwill	514.27M	515M	518.59M	703.37M	717.74M	716.33M	757.04M	773.31M
Intangible Assets	459.62M	428M	396.44M	511.82M	486.78M	487.04M	485.21M	447.48M
Long-Term Investments	1.16M	0	0	0	0	0	0	0
Other Non-Current Assets	1.26M	1.1M	1.16M	2.17M	5.62M	3.05M	2.03M	1.64M
Total Assets	1.05B▲ 0%	1.04B▼ 1.4%	1.27B▲ 22.4%	1.51B▲ 19.1%	1.57B▲ 4.0%	1.56B▼ 0.6%	1.58B▲ 0.8%	1.56B▼ 1.2%
Asset Turnover	0.16x	0.20x	0.19x	0.19x	0.21x	0.23x	0.24x	0.27x
Asset Growth %	-	-1.37%	22.4%	19.09%	4.05%	-0.62%	0.77%	-1.18%
Total Current Liabilities	65.45M	63M	75.34M	92.22M	103.16M	130.02M	146.09M	153.38M
Accounts Payable	4.91M	4.92M	6.39M	7.46M	7.53M	5.17M	3.5M	3.43M
Days Payables Outstanding	25.22	22.5	23.16	24.39	20.74	13.38	8.27	7.76
Short-Term Debt	3.15M	4.21M	4.68M	3.02M	3.02M	3.02M	3M	2.96M
Deferred Revenue (Current)	37.52M	26.24M	30.66M	45.5M	52.21M	60.68M	77.83M	75.41M
Other Current Liabilities	12.58M	8.35M	29.45M	26.95M	31.01M	49.51M	53.08M	75.01M
Current Ratio	1.05x	1.39x	4.60x	2.98x	3.32x	2.62x	2.13x	2.05x
Quick Ratio	0.97x	1.39x	4.60x	2.98x	3.32x	2.62x	2.13x	2.05x
Cash Conversion Cycle	114.42	-	-	-	-	-	-	-
Total Non-Current Liabilities	493.27M	482.02M	371.92M	377.66M	390.1M	386.28M	370.36M	340.4M
Long-Term Debt	404.8M	397.12M	294.1M	291.75M	289.99M	288.22M	292.43M	8.44M
Capital Lease Obligations	48K	0	318K	8.28M	10.13M	6.96M	11.17M	0
Deferred Tax Liabilities	85.67M	82.16M	75.89M	76.1M	67.35M	50.83M	40.42M	34.37M
Other Non-Current Liabilities	0	1.6M	1.07M	0	19.81M	39.21M	25.3M	297.6M
Total Liabilities	558.72M	545.02M	447.27M	469.88M	493.26M	516.3M	516.45M	493.79M
Total Debt	408.28M	401.38M	299.37M	308.38M	308.13M	302.57M	311.9M	11.4M
Net Debt	396.6M	372.12M	27.99M	122.58M	71.55M	67.62M	132.71M	-177.99M
Debt / Equity	0.83x	0.82x	0.36x	0.30x	0.29x	0.29x	0.29x	0.01x
Debt / EBITDA	12.62x	6.56x	16.33x	5.25x	3.63x	19.78x	4.70x	0.15x
Net Debt / EBITDA	12.26x	6.08x	1.53x	2.09x	0.84x	4.42x	2.00x	-2.29x
Interest Coverage	-0.17x	0.70x	-0.97x	0.81x	1.83x	-1.78x	-0.08x	-
Total Equity	492.77M▲ 0%	492.05M▼ 0.1%	822.13M▲ 67.1%	1.04B▲ 26.7%	1.08B▲ 3.6%	1.05B▼ 3.0%	1.06B▲ 1.1%	1.06B▲ 0.4%
Equity Growth %	-	-0.15%	67.08%	26.73%	3.63%	-3.04%	1.13%	0.39%
Book Value per Share	3.72	3.13	5.37	6.95	6.78	6.59	6.60	6.63
Total Shareholders' Equity	492.77M	492.05M	822.13M	1.04B	1.08B	1.05B	1.06B	1.06B
Common Stock	1.32M	1.32M	1.53M	1.6M	1.6M	1.6M	1.62M	1.64M
Retained Earnings	-14.43M	-12.94M	-62.34M	-75.6M	-60.87M	-116.23M	-128.28M	-129.88M
Treasury Stock	0	0	0	-38K	-3M	-9.4M	-18.18M	0
Accumulated OCI	-1.65M	-5.5M	-1.59M	-3.93M	-8.23M	-7.59M	-13.42M	2.04M
Minority Interest	0	0	0	0	0	0	0	0

CERT Cash Flow Statement

Certara, Inc. (CERT) cash flow — operating, investing & free cash flow history

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	11.59M	38.02M	44.81M	60.39M	92.54M	82.75M	80.47M	96.33M
Operating CF Margin %	7.08%	18.24%	18.4%	21.11%	27.57%	23.35%	20.89%	23%
Operating CF Growth %	-	228.03%	17.84%	34.76%	53.25%	-10.58%	-2.77%	19.71%
Net Income	-33.26M	-8.93M	-49.4M	-13.27M	14.73M	-55.36M	-12.05M	-1.59M
Depreciation & Amortization	37.01M	41.56M	42.75M	45.12M	54.01M	57.6M	68.03M	75.16M
Stock-Based Compensation	1.71M	1.69M	64.51M	29.48M	30.35M	28.3M	34.77M	33.08M
Deferred Taxes	-3.55M	-6.7M	-7.83M	-1.18M	0	0	-12.7M	-8.32M
Other Non-Cash Items	1.36M	1.66M	1.49M	3.16M	8.34M	51.35M	10.59M	-2M
Working Capital Changes	8.32M	8.74M	-6.71M	-2.92M	-14.88M	863K	-8.18M	0
Change in Receivables	-2.03M	-1.52M	-3.93M	-10.07M	-15.01M	152K	-16.23M	428K
Change in Inventory	-2.61M	0	0	0	0	0	0	0
Change in Payables	-6.36M	10.03M	2.38M	0	0	0	-4.76M	4.4M
Cash from Investing	-73.91M	-9.52M	-8.61M	-269.92M	-27.84M	-79.55M	-112.37M	-26.56M
Capital Expenditures	-11.48M	-2.11M	-7.94M	-8.9M	-1.43M	-1.78M	-1.63M	-1.76M
CapEx % of Revenue	7.02%	1.01%	3.26%	3.11%	0.43%	0.5%	0.42%	0.42%
Acquisitions	-62.42M	0	-675K	-261.02M	-15.31M	-64.23M	-91.33M	-13.23M
Investments	-	-	-	-	-	-	-	-
Other Investing	-6.73M	-7.41M	0	0	-11.1M	-13.55M	-19.42M	-11.57M
Cash from Financing	57.3M	-8.49M	208.21M	123.39M	-7.36M	-9.45M	-21.01M	-63.99M
Debt Issued (Net)	66.02M	-8.44M	-104.36M	-3.88M	-3.31M	-3.04M	4.05M	0
Equity Issued (Net)	10K	-53K	1000K	1000K	-1000K	-1000K	-1000K	0
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	-1.1M	-703K	-1.08M	0	-2.96M	-6.4M	-8.69M	-42.61M
Other Financing	-8.73M	0	-2.9M	-6.08M	-1.09M	0	-16.37M	-63.99M
Net Change in Cash	-6.35M▲ 0%	17.57M▲ 376.6%	243.53M▲ 1285.7%	-86.67M▼ 135.6%	53.06M▲ 161.2%	-4.74M▼ 108.9%	-55.77M▼ 1077.3%	10.21M▲ 118.3%
Free Cash Flow	107K▲ 0%	28.51M▲ 26543.0%	36.87M▲ 29.3%	51.49M▲ 39.6%	91.11M▲ 77.0%	80.98M▼ 11.1%	78.84M▼ 2.6%	94.56M▲ 19.9%
FCF Margin %	0.07%	13.67%	15.14%	18%	27.15%	22.85%	20.47%	22.58%
FCF Growth %	-	26542.99%	29.34%	39.63%	76.97%	-11.12%	-2.64%	19.94%
FCF per Share	0.00	0.18	0.24	0.34	0.57	0.51	0.49	0.59
FCF Conversion (FCF/Net Income)	-0.35x	-4.26x	-0.91x	-4.55x	6.28x	-1.49x	-6.68x	-60.39x
Interest Paid	25.71M	26.43M	27.61M	14.17M	17.27M	19.09M	22.74M	0
Taxes Paid	3.17M	4.11M	12.28M	8.6M	0	0	14.66M	0

CERT Key Ratios

Certara, Inc. (CERT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-6.75%	-1.81%	-7.52%	-1.42%	1.39%	-5.21%	-1.14%	-0.15%
Return on Invested Capital (ROIC)	-0.39%	1.68%	-2.14%	1.01%	2.11%	-2.7%	-0.11%	1.52%
Gross Margin	56.61%	61.74%	58.62%	60.99%	60.5%	60.2%	59.88%	61.53%
Net Margin	-20.31%	-4.28%	-20.28%	-4.64%	4.39%	-15.62%	-3.13%	-0.38%
Debt / Equity	0.83x	0.82x	0.36x	0.30x	0.29x	0.29x	0.29x	0.01x
Interest Coverage	-0.17x	0.70x	-0.97x	0.81x	1.83x	-1.78x	-0.08x	-
FCF Conversion	-0.35x	-4.26x	-0.91x	-4.55x	6.28x	-1.49x	-6.68x	-60.39x
Revenue Growth	-	27.36%	16.79%	17.48%	17.32%	5.57%	8.7%	8.75%

CERT SEC Filings & Documents

Certara, Inc. (CERT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Mar 31, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Dec 11, 2025·SEC

10-K Annual Reports

FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 5, 2025·SEC

CERT Frequently Asked Questions

Certara, Inc. (CERT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Certara, Inc. (CERT) reported $418.8M in revenue for fiscal year 2025. This represents a 156% increase from $163.7M in 2018.

Certara, Inc. (CERT) grew revenue by 8.7% over the past year. This is steady growth.

Certara, Inc. (CERT) reported a net loss of $1.6M for fiscal year 2025.

Dividend & Returns

Certara, Inc. (CERT) has a return on equity (ROE) of -0.2%. Negative ROE indicates the company is unprofitable.

Certara, Inc. (CERT) generated $66.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CERT

Certara, Inc. (CERT) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Certara, Inc.(CERT)Earnings, Financials & Key Ratios

CERT Key Insights

✓Strengths

✗Weaknesses

CERT Price & Volume

CERT Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

CERT Recent Earnings

CERT Peer Comparison

Compare CERT vs Peers

vs MEDP

vs LLY

Compare Top 5

CERT Income Statement

CERT Balance Sheet

CERT Cash Flow Statement

CERT Key Ratios

CERT SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

CERT Frequently Asked Questions

Explore More CERT

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation